152 related articles for article (PubMed ID: 15979909)
1. Purmorphamine enhances osteogenic activity of human osteoblasts derived from bone marrow mesenchymal cells.
Beloti MM; Bellesini LS; Rosa AL
Cell Biol Int; 2005 Jul; 29(7):537-41. PubMed ID: 15979909
[TBL] [Abstract][Full Text] [Related]
2. The effect of purmorphamine on osteoblast phenotype expression of human bone marrow mesenchymal cells cultured on titanium.
Beloti MM; Bellesini LS; Rosa AL
Biomaterials; 2005 Jul; 26(20):4245-8. PubMed ID: 15683647
[TBL] [Abstract][Full Text] [Related]
3. The effect of purmorphamine and sirolimus on osteogenic differentiation of human bone marrow-derived mesenchymal stem cells.
Faghihi F; Baghaban Eslaminejad M; Nekookar A; Najar M; Salekdeh GH
Biomed Pharmacother; 2013 Feb; 67(1):31-8. PubMed ID: 23228449
[TBL] [Abstract][Full Text] [Related]
4. TAK-778 enhances osteoblast differentiation of human bone marrow cells.
Rosa AL; Beloti MM
J Cell Biochem; 2003 Aug; 89(6):1148-53. PubMed ID: 12898513
[TBL] [Abstract][Full Text] [Related]
5. Chronic ethanol intake inhibits in vitro osteogenesis induced by osteoblasts differentiated from stem cells.
Rosa ML; Beloti MM; Prando N; Queiroz RH; de Oliveira PT; Rosa AL
J Appl Toxicol; 2008 Mar; 28(2):205-11. PubMed ID: 17582586
[TBL] [Abstract][Full Text] [Related]
6. Nitroglycerin enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via nitric oxide pathway.
Huang L; Qiu N; Zhang C; Wei HY; Li YL; Zhou HH; Xiao ZS
Acta Pharmacol Sin; 2008 May; 29(5):580-6. PubMed ID: 18430366
[TBL] [Abstract][Full Text] [Related]
7. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts.
Heino TJ; Hentunen TA; Väänänen HK
Exp Cell Res; 2004 Apr; 294(2):458-68. PubMed ID: 15023534
[TBL] [Abstract][Full Text] [Related]
8. Effect of ibuprofen on osteoblast differentiation of porcine bone marrow-derived progenitor cells.
Abukawa H; Phelps M; Jackson P; Smith RM; Vacanti JP; Kaban LB; Troulis MJ
J Oral Maxillofac Surg; 2009 Nov; 67(11):2412-7. PubMed ID: 19837310
[TBL] [Abstract][Full Text] [Related]
9. TAK-778 enhances osteoblast differentiation of human bone marrow cells via an estrogen-receptor-dependent pathway.
Rosa AL; Beloti MM
J Cell Biochem; 2004 Mar; 91(4):749-55. PubMed ID: 14991766
[TBL] [Abstract][Full Text] [Related]
10. The influence of proepicardial cells on the osteogenic potential of marrow stromal cells in a three-dimensional tubular scaffold.
Valarmathi MT; Yost MJ; Goodwin RL; Potts JD
Biomaterials; 2008 May; 29(14):2203-16. PubMed ID: 18289664
[TBL] [Abstract][Full Text] [Related]
11. Osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)] acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes.
Chen ZX; Chang M; Peng YL; Zhao L; Zhan YR; Wang LJ; Wang R
Regul Pept; 2007 Jul; 142(1-2):16-23. PubMed ID: 17331598
[TBL] [Abstract][Full Text] [Related]
12. Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells.
Seib FP; Franke M; Jing D; Werner C; Bornhäuser M
Eur J Cell Biol; 2009 May; 88(5):257-71. PubMed ID: 19303661
[TBL] [Abstract][Full Text] [Related]
13. Purmorphamine increased adhesion, proliferation and expression of osteoblast phenotype markers of human dental pulp stem cells cultured on beta-tricalcium phosphate.
Rezia Rad M; Khojaste M; Hasan Shahriari M; Asgary S; Khojasteh A
Biomed Pharmacother; 2016 Aug; 82():432-8. PubMed ID: 27470382
[TBL] [Abstract][Full Text] [Related]
14. Effects of culture conditions on osteogenic differentiation in human mesenchymal stem cells.
Song SJ; Jeon O; Yang HS; Han DK; Kim BS
J Microbiol Biotechnol; 2007 Jul; 17(7):1113-9. PubMed ID: 18051321
[TBL] [Abstract][Full Text] [Related]
15. The effects of various irradiation doses on the growth and differentiation of marrow-derived human mesenchymal stromal cells.
Li J; Kwong DL; Chan GC
Pediatr Transplant; 2007 Jun; 11(4):379-87. PubMed ID: 17493217
[TBL] [Abstract][Full Text] [Related]
16. On the role of subtype selective adenosine receptor agonists during proliferation and osteogenic differentiation of human primary bone marrow stromal cells.
Costa MA; Barbosa A; Neto E; Sá-e-Sousa A; Freitas R; Neves JM; Magalhães-Cardoso T; Ferreirinha F; Correia-de-Sá P
J Cell Physiol; 2011 May; 226(5):1353-66. PubMed ID: 20945394
[TBL] [Abstract][Full Text] [Related]
17. The effect of recombinant human bone morphogenetic protein-2 on the osteogenic potential of rat mesenchymal stem cells after several passages.
Ishikawa H; Kitoh H; Sugiura F; Ishiguro N
Acta Orthop; 2007 Apr; 78(2):285-92. PubMed ID: 17464620
[TBL] [Abstract][Full Text] [Related]
18. Tissue-engineered bone formation using human bone marrow stromal cells and novel beta-tricalcium phosphate.
Liu G; Zhao L; Cui L; Liu W; Cao Y
Biomed Mater; 2007 Jun; 2(2):78-86. PubMed ID: 18458439
[TBL] [Abstract][Full Text] [Related]
19. Purmorphamine and oxysterols accelerate and promote osteogenic differentiation of mesenchymal stem cells in vitro.
Wöltje M; Böbel M; Heiland M; Beck-Broichsitter B; Al-Dam A; Gröbe A; Friedrich RE; Hanken H; Smeets R
In Vivo; 2015; 29(2):247-54. PubMed ID: 25792653
[TBL] [Abstract][Full Text] [Related]
20. Virtual ligand-based screening reveals purmorphamine analogs with the capacity to induce the osteogenic differentiation of human mesenchymal stem cells.
Granéli C; Karlsson C; Lindahl A; Thomsen P
Cells Tissues Organs; 2013; 197(2):89-102. PubMed ID: 23147751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
